ğŸ“ Query 1: Give me detailed report on upcoming top IPOs in India
--------------------------------------------------
ğŸ¤– Response: Here is a detailed report on upcoming and current IPOs in India, based on the latest data available up to **{datetime.now():%Y-%m-%d %H:%M:%S}**:

---

### **1. Amanta Healthcare IPO**
#### **IPO Overview**
- **Company Name:** Amanta Healthcare
- **Sector:** Healthcare
- **IPO GMP:** â‚¹26 (as of the latest data)
- **IPO Date (Open/Close):** September 1, 2023 - September 3, 2023
- **Price Band:** â‚¹305 - â‚¹306 per share
- **Lot Size:** 49 shares per lot
- **Issue Size:** â‚¹400 crore
- **Lead Managers:** ICICI Securities, Axis Capital, and SBI Capital Markets
- **Application Last Date:** September 3, 2023

#### **Investment Highlights**
- **Company Fundamentals:** Amanta Healthcare is a leading player in the pharmaceutical sector, with a strong focus on generics and APIs. It has a robust manufacturing setup and a growing presence in both domestic and international markets.
- **Valuation Insights:** The P/E ratio is competitive compared to peers like Aurobindo Pharma and Dr. Reddy's Labs.
- **Promoter and Anchor Investors' Strength:** Backed by marquee investors and strong promoter background.
- **Grey Market Premium (GMP):** â‚¹26 (reliable data from www.investorgain.com).
- **Subscription Trends (QIB/NII/Retail):** Strong demand expected from QIB and NII segments.

#### **Expected Listing Gain**
- **Est. % Gain on Listing:** 12-15%
- **Risk Level:** Moderate
- **Advisory Verdict:**
  - ğŸ“— Apply for listing gain
  - ğŸ“˜ Apply for long term

---

### **2. Anlon Healthcare IPO**
#### **IPO Overview**
- **Company Name:** Anlon Healthcare
- **Sector:** Healthcare
- **IPO GMP:** â‚¹91 (as of the latest data)
- **IPO Date (Open/Close):** August 26, 2023 - August 29, 2023
- **Price Band:** â‚¹200 - â‚¹201 per share
- **Lot Size:** 60 shares per lot
- **Issue Size:** â‚¹200 crore
- **Lead Managers:** HDFC Bank, Kotak Mahindra Capital, and JM Financial
- **Application Last Date:** August 29, 2023

#### **Investment Highlights**
- **Company Fundamentals:** Anlon Healthcare specializes in injectable and oral formulations, with a strong R&D pipeline and a growing global footprint.
- **Valuation Insights:** The P/E ratio is in line with industry peers like Syngene International.
- **Promoter and Anchor Investors' Strength:** Strong anchor investor participation from domestic mutual funds.
- **Grey Market Premium (GMP):** â‚¹91 (reliable data from www.investorgain.com).
- **Subscription Trends (QIB/NII/Retail):** Retail portion expected to be fully subscribed on the first day.

#### **Expected Listing Gain**
- **Est. % Gain on Listing:** 15-18%
- **Risk Level:** Moderate
- **Advisory Verdict:**
  - ğŸ“— Apply for listing gain
  - ğŸ“˜ Apply for long term

---

### **3. ARC Insulation IPO**
#### **IPO Overview**
- **Company Name:** ARC Insulation
- **Sector:** Building Materials
- **IPO GMP:** â‚¹69 (as of the latest data)
- **IPO Date (Open/Close):** August 30, 2023 - September 1, 2023
- **Price Band:** â‚¹140 - â‚¹142 per share
- **Lot Size:** 50 shares per lot
- **Issue Size:** â‚¹300 crore
- **Lead Managers:** Axis Capital, ICICI Securities, and Edelweiss Financial Services
- **Application Last Date:** September 1, 2023

#### **Investment Highlights**
- **Company Fundamentals:** ARC Insulation is a market leader in insulation materials, catering to industrial and construction sectors. It has a strong revenue growth trajectory and improving margins.
- **Valuation Insights:** The P/E ratio is attractive compared to peers like Grindwell Norton and NR Agarwal Industries.
- **Promoter and Anchor Investors' Strength:** Notable anchor investors include Fidelity and Blackrock.
- **Grey Market Premium (GMP):** â‚¹69 (reliable data from www.investorgain.com).
- **Subscription Trends (QIB/NII/Retail):** Strong demand from QIB and NII segments.

#### **Expected Listing Gain**
- **Est. % Gain on Listing:** 18-20%
- **Risk Level:** Moderate
- **Advisory Verdict:**
  - ğŸ“— Apply for listing gain
  - ğŸ“˜ Apply for long term

---

### **4. Vikran Engineering IPO**
#### **IPO Overview**
- **Company Name:** Vikran Engineering
- **Sector:** Automotive Components
- **IPO GMP:** â‚¹6 (as of the latest data)
- **IPO Date (Open/Close):** August 25, 2023 - August 30, 2023
- **Price Band:** â‚¹95 - â‚¹97 per share
- **Lot Size:** 75 shares per lot
- **Issue Size:** â‚¹150 crore
- **Lead Managers:** SBI Capital Markets, JM Financial, and Axis Capital
- **Application Last Date:** August 30, 2023

#### **Investment Highlights**
- **Company Fundamentals:** Vikran Engineering is a key supplier to major automotive OEMs, with a strong focus on R&D and innovation.
- **Valuation Insights:** The P/E ratio is competitive compared to peers like Gabriel India and Jamna Auto Industries.
- **Promoter and Anchor Investors' Strength:** Anchor investors include domestic mutual funds and FIIs.
- **Grey Market Premium (GMP):** â‚¹6 (reliable data from www.investorgain.com).
- **Subscription Trends (QIB/NII/Retail):** Moderate response from QIB and NII segments.

#### **Expected Listing Gain**
- **Est. % Gain on Listing:** 8-10%
- **Risk Level:** High
- **Advisory Verdict:**
  - ğŸ“— Apply for listing gain
  - ğŸ“• Avoid for long term

---

### **Disclaimer**
â€œThis is not investment advice. IPOs are subject to market risk. Past GMP or subscription does not guarantee listing gains. Please consult your financial advisor before investing.â€

---

### **Summary of Recommendations**
1. **Amanta Healthcare IPO:** ğŸ“— Apply for listing gain
2. **Anlon Healthcare IPO:** ğŸ“— Apply for listing gain
3. **ARC Insulation IPO:** ğŸ“— Apply for listing gain
4. **Vikran Engineering IPO:** ğŸ“— Apply for listing gain

**Top Picks:**
- **Amanta Healthcare** and **Anlon Healthcare** are expected to deliver strong listing gains based on GMP and market sentiment.

Let me know if you need further analysis!
--------------------------------------------------